Alcohol and Other Psychoactive Substances in Road Traffic - a Case-control Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by National Institute for Health and Welfare, Finland.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Hospital District of Helsinki and Uusimaa
European Commission
Information provided by (Responsible Party):
National Institute for Health and Welfare, Finland
ClinicalTrials.gov Identifier:
NCT00570518
First received: December 10, 2007
Last updated: September 30, 2011
Last verified: September 2011

December 10, 2007
September 30, 2011
September 2007
Not Provided
relative risk estimation of accident involvement for drivers impaired by psychoactive substances [ Time Frame: three years ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00570518 on ClinicalTrials.gov Archive Site
  • prevalence of psychoactive substances in the general driving population [ Time Frame: three years ] [ Designated as safety issue: Yes ]
  • prevalence of psychoactive substances among accident involved drivers [ Time Frame: three years ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Alcohol and Other Psychoactive Substances in Road Traffic - a Case-control Study
DRUID Work Package 2 - Epidemiology

The main purpose of the study is to determine the accident risk when driving under the influence of psychoactive substances, including alcohol (DUI). Other aims are to find out the prevalence of psychoactive substances in road traffic and to obtain information on the role of these substances in road traffic accident causations.

For the purposes of the study, drivers of motorised vehicles are randomly stopped and interviewed and breath alcohol is recorded. Also, an oral fluid sample is taken and psychoactive substances are investigated in the laboratory. For cases, drivers injured in traffic accidents are asked to participate to the study. A whole blood sample and, if possible, an oral fluid sample is taken and psychoactive substances are determined in the laboratory. Also, people diseased in road traffic accident are included in the study. The information required for these subjects are taken from a register database.

The study is part of an EU-project DRUID. Altogether 13 European countries take part to the study.

Not Provided
Observational
Observational Model: Case Control
Not Provided
Retention:   Samples With DNA
Description:

Whole blood and oral fluid are collected for the study. However, no DNA determinations are done at any point of the study. The laboratory where the samples are analysed does not analyse DNA. DNA is not relevant for this study.

Non-Probability Sample

drivers of motorised vehicles and bicycles in general road traffic or drivers of motorised vehicles and bicycles, injured or killed in road traffic accidents

  • Prevalence of Psychoactive Substances in Road Traffic
  • Psychoactive Substances in Accident Involved Drivers
  • Relative Risk Estimation of Accident Involvement for Impaired Drivers
Not Provided
  • 1
    randomly stopped drivers of motorised vehicles and bicycles
  • 2
    drivers of motorised vehicles and bicycles injured or killed in road traffic accidents
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
4500
October 2011
Not Provided

Inclusion Criteria:

  • 18 years or older
  • driver of a motorised vehicle or bicycle
  • is willing to participate to the study (not applicable to the diseased drivers; information obtained from a register database)

Exclusion Criteria:

  • 17 or younger
  • not the driver of a motorised vehicle or bicycle
  • does not want to participate (not applicable to the diseased drivers; information obtained from a register database)
Both
18 Years and older
Yes
Contact: Pirjo Lillsunde, Dr +358947448342 pirjo.lillsunde@ktl.fi
Contact: Charlotta Engblom, M.Sc.(Tech.) +358947448546 charlotta.engblom@ktl.fi
Finland
 
NCT00570518
KTL 403-2, 404-3, 405-9, 406-5
No
National Institute for Health and Welfare, Finland
National Institute for Health and Welfare, Finland
  • Hospital District of Helsinki and Uusimaa
  • European Commission
Principal Investigator: Pirjo Lillsunde, Dr National Public Health Institute
National Institute for Health and Welfare, Finland
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP